COMP <GO>
FATE vs IKT // 10Y YIELD & FRED MACRO BETA
Fate Therapeutics Inc. (NASDAQ) VS. Inhibikase Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: FATE 3
— IKT 0
■ METRIC PARITY
LAST: $2.17 (0.00%) • MKT CAP: $260.0M
macro-sensitivity
—
LAST: $1.67 (+3.09%) • MKT CAP: $233.0M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FATE VS. IKT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FATE | IKT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -11.93% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -51.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | FATE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.8 | 33.6 | +17.18 | FATE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $260.0M | $233.0M | $27.0M | FATE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FATE REV | IKT REV | FATE GROSS % | IKT GROSS % | FATE FCF | IKT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.6M | $0 | — | — | -$112.0M | -$27.8M |
| FY 2024 | $13.6M | $0 | — | — | -$123.6M | -$19.1M |
| FY 2023 | $63.5M | $260.5K | — | — | -$132.3M | -$18.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FATE // BETA —
IKT // BETA —